UK-based healthcare technology company Huma raised over $80 million in a Series D funding round, totaling over $300 million in investments. New and existing investors like AstraZeneca and Bayer participated. Huma launched the Huma Cloud Platform for integrating patient data, AI, and predictive algorithms for disease management tools. Thyme Care, a cancer care platform, raised $60 million in Series B financing, bringing its total raise to over $80 million. Neuspera Medical, Inc., closed its Series D funding round with $23 million for its implantable sacral neuromodulation system to help with urinary incontinence. The HIMSS AI in Healthcare Forum is scheduled for September.
Source link